Diabetes and heart failure. Update 2017

被引：1
作者：
Schuett, K. [1 ]
Marx, N. [1 ]
机构：
[1] Rhein Westfal TH Aachen, Med Klin Kardiol Pneumol Angiol & Internist Inten, Univ Klinikum Aachen, Pauwelsstr 30, D-52074 Aachen, Germany
来源：
HERZ | 2017年 / 42卷 / 03期
关键词：
Diabetes mellitus; Heart failure; Antidiabetic therapy; Heart failure treatment; Diagnostics; CARDIOVASCULAR OUTCOMES; GLUCOSE ABNORMALITIES; TYPE-2; MORTALITY; RISK; METFORMIN; EMPAGLIFLOZIN; ASSOCIATION; GUIDELINES;
D O I：
10.1007/s00059-017-4558-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with diabetes mellitus exhibit an increased risk for the development of heart failure. The occurrence of heart failure in patients with diabetes is associated with a poor prognosis. Therapeutic strategies to reduce cardiovascular morbidity and mortality in diabetes have so far mainly focused on the prevention of coronary events but recent data suggest that an early diagnosis of heart failure in diabetes as well as specific therapies could have a major impact on the prognosis for these patients. This article aims to provide a comprehensive overview on the epidemiology, pathophysiology and prognosis of heart failure in diabetes patients and addresses current aspects of heart failure therapy in diabetes as well as diabetes therapy in heart failure patients.
引用
收藏
页码：329 / 340
页数：12
相关论文
共 31 条
  • [1] Metformin Use and Mortality in Ambulatory Patients With Diabetes and Heart Failure
    Aguilar, David
    Chan, Wenyaw
    Bozkurt, Biykem
    Ramasubbu, Kumudha
    Deswal, Anita
    [J]. CIRCULATION-HEART FAILURE, 2011, 4 (01) : 53 - 58
  • [2] Novel metabolic risk factors for incident heart failure and their relationship with obesity
    Bahrami, Hossein
    Bluemke, David A.
    Kronmal, Richard
    Bertoni, Alain G.
    Lloyd-Jones, Donald M.
    Shahar, Eyal
    Szklo, Moyses
    Lima, Joao A. C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (18) : 1775 - 1783
  • [3] Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: Findings from a population-based cohort study
    Deedwania, Prakash
    Patel, Kanan
    Fonarow, Gregg C.
    Desai, Ravi V.
    Zhang, Yan
    Feller, Margaret A.
    Ovalle, Fernando
    Love, Thomas E.
    Aban, Inmaculada B.
    Mujib, Marjan
    Ahmed, Mustafa I.
    Anker, Stefan D.
    Ahmed, Ali
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 3616 - 3622
  • [4] Diabetes and the Heart - a Never-ending Story
    Doerr, Rolf
    Mueller-Wieland, Dirk
    Tschoepe, Diethelm
    [J]. HERZ, 2010, 35 (03) : 129 - 129
  • [5] Diabetic cardiomyopathy: Myth or reality?
    Ernande, Laura
    Derumeaux, Genevieve
    [J]. ARCHIVES OF CARDIOVASCULAR DISEASES, 2012, 105 (04) : 218 - 225
  • [6] Effect of Metformin on Mortality in Patients With Heart Failure and Type 2 Diabetes Mellitus
    Evans, Josie M. M.
    Doney, Alex S. F.
    AlZadjali, Matlooba A.
    Ogston, Simon A.
    Petrie, John R.
    Morris, Andrew D.
    Struthers, Allan D.
    Wong, Aaron K. F.
    Lang, Chim C.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (07) : 1006 - 1010
  • [7] Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial
    Fitchett, David
    Zinman, Bernard
    Wanner, Christoph
    Lachin, John M.
    Hantel, Stefan
    Salsali, Afshin
    Johansen, Odd Erik
    Woerle, Hans J.
    Broedl, Uli C.
    Inzucchi, Silvio E.
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (19) : 1526 - 1534
  • [8] Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
    Green, Jennifer B.
    Bethel, M. Angelyn
    Armstrong, Paul W.
    Buse, John B.
    Engel, Samuel S.
    Garg, Jyotsna
    Josse, Robert
    Kaufman, Keith D.
    Koglin, Joerg
    Korn, Scott
    Lachin, John M.
    McGuire, Darren K.
    Pencina, Michael J.
    Standl, Eberhard
    Stein, Peter P.
    Suryawanshi, Shailaja
    Van de Werf, Frans
    Peterson, Eric D.
    Holman, Rury R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (03) : 232 - 242
  • [9] Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure
    Gustafsson, I
    Brendorp, B
    Seibæk, M
    Burchardt, H
    Hildebrandt, P
    Kober, L
    Torp-Pedersen, C
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 771 - 777
  • [10] Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
    Inzucchi, Silvio E.
    Bergenstal, Richard M.
    Buse, John B.
    Diamant, Michaela
    Ferrannini, Ele
    Nauck, Michael
    Peters, Anne L.
    Tsapas, Apostolos
    Wender, Richard
    Matthews, David R.
    [J]. DIABETES CARE, 2015, 38 (01) : 140 - 149
1234